US5364778A - Copolymer production - Google Patents
Copolymer production Download PDFInfo
- Publication number
- US5364778A US5364778A US08/103,155 US10315593A US5364778A US 5364778 A US5364778 A US 5364778A US 10315593 A US10315593 A US 10315593A US 5364778 A US5364778 A US 5364778A
- Authority
- US
- United States
- Prior art keywords
- component
- copolymer
- bacterium
- growth
- monomer units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 241000894006 Bacteria Species 0.000 claims abstract description 47
- 239000000178 monomer Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 30
- 230000002906 microbiologic effect Effects 0.000 claims abstract description 5
- 239000000758 substrate Substances 0.000 claims description 29
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000012736 aqueous medium Substances 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 13
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000019260 propionic acid Nutrition 0.000 claims description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 230000037353 metabolic pathway Effects 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical group CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 241000588986 Alcaligenes Species 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims 2
- 241000252867 Cupriavidus metallidurans Species 0.000 abstract description 17
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 abstract 1
- UQGPCEVQKLOLLM-UHFFFAOYSA-N pentaneperoxoic acid Chemical compound CCCCC(=O)OO UQGPCEVQKLOLLM-UHFFFAOYSA-N 0.000 abstract 1
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 119
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 22
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 20
- 238000009825 accumulation Methods 0.000 description 17
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 15
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 13
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 12
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- ACFIXJIJDZMPPO-NNYOXOHSSA-J NADPH(4-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-J 0.000 description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- -1 acetyl thioester Chemical class 0.000 description 3
- 235000020774 essential nutrients Nutrition 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000013048 microbiological method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- YNCMLFHHXWETLD-UHFFFAOYSA-N pyocyanin Chemical compound CN1C2=CC=CC=C2N=C2C1=CC=CC2=O YNCMLFHHXWETLD-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229920001791 ((R)-3-Hydroxybutanoyl)(n-2) Polymers 0.000 description 1
- NVPCGXUWUBHZBD-UHFFFAOYSA-N 3-hydroxybut-2-enoic acid Chemical group CC(O)=CC(O)=O NVPCGXUWUBHZBD-UHFFFAOYSA-N 0.000 description 1
- QHHKKMYHDBRONY-RMNRSTNRSA-N 3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-RMNRSTNRSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000600898 Nocardia salmonicolor Species 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N Xylose Natural products O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RIUKRCNLZYDWHS-UHFFFAOYSA-N ethane;methanesulfonic acid Chemical compound CC.CS(O)(=O)=O RIUKRCNLZYDWHS-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/829—Alcaligenes
Definitions
- This invention relates to a microbiological method of producing copolymers comprising 3-hydroxybutyrate (HB) monomer units and 3-hydroxyvalerate (HV) monomer units and to a new micro-organism suitably adapted for use in such a microbiological method.
- HB 3-hydroxybutyrate
- HV 3-hydroxyvalerate
- Homopolymer consisting of HB monomer units, known as polyhydroxybutyrate (PHB) is accumulated by various micro-organisms, principally bacteria, as an energy reserve material as granules within the microbial cells.
- PHB polyhydroxybutyrate
- Copolymers comprising HB monomer units and a minor proportion of dissimilar units may be produced by the cultivation of certain micro-organisms, under certain conditions in the presence of certain acids, and alcohols.
- Wallen et al describe, in "Environmental Science and Technology” 6 (1972) pages 161 to 164 and 8 (1974) pages 576 to 579, a polymer melting at 97° to 100° C. (after repeated washing) isolated from activated sludges and containing 3-hydroxybutyrate units and 3-hydroxyvalerate units, i.e.
- U.S. Pat. No. 3,275,610 describes the microbiological production of polyesters by cultivating certain micro-organisms, especially Nocardia salmonicolor, on carboxylic acids containing 4 carbon atoms.
- European Patent Specification 0069497 describes the microbial production of a number of polyesters by cultivating certain micro-organisms especially Alcaligenes eutrophus mutant NCIB 11599 on suitable substrates.
- a substrate i.e. a source of energy and carbon
- the bacteria are required to be cultivated on a substrate comprising a component from which HV is capable of being synthesised, e.g. propionic acid.
- the component that gives rise to the HV monomer units within the copolymer is herein termed the HV component of the substrate.
- Specific cultivation conditions are normally needed order to induce PHB production, and accumulation, in known bacteria. Such specific cultivation conditions are also necessary to induce copolymer production, and accumulation.
- Some known bacteria produce PHB constitutively, i.e. do not need to be cultivated under specific conditions in order to produce, and accumulate PHB. Nevertheless, unless the aforementioned specific cultivation conditions are employed, even those known strains which produce PHB constitutively may metabolise an HV component such that copolymer is not produced and accumulated.
- the HV component may give rise to non-monomer material, or may be used to synthesise HB monomer units for incorporation into the copolymer, even if the HV component is the sole substrate during the polymer accumulation stage.
- the metabolism of the HV component, so as to synthesise HB monomer units may occur to such an extent that significantly less than half of the HV component is converted into the required HV monomer units, and results in the production of copolymers having low percentage levels of HV monomer units.
- the bacteria are required to be provided with a large excess of the HV component.
- a microbiological process for the production of copolymers comprising HB and HV monomer units using a PHB accumulating bacterium which is not capable of significant growth when cultivated under non growth limiting conditions on a substrate consisting essentially of an HV component which process comprises cultivating the bacterium in an aqueous medium at a desired weight of dry cells per liter of medium, under growth limitation conditions conducive to the bacterium synthesising and accumulating copolymer, and thereafter harvesting the copolymer containing bacterium wherein the medium comprises a substrate, and the substrate comprises a water soluble assimilable carbon containing HV component and a water soluble assimilable carbon containing HB component.
- the process conditions under which the bacterium is cultivated i.e. temperature, pH, aeration, essential nutrients, may be similar to those commonly used in PHB accumulation processes.
- Those essential nutrients required for the growth of the bacterium comprise the following elements, which are normally present in readily assimilable form, normally as water soluble salts: nitrogen, phosphorus, sulphur, potassium, sodium, magnesium, calcium, and iron, together with traces of manganese, zinc and copper.
- At least part of the cultivation is conducted under growth limitation conditions, i.e. under conditions wherein an essential requirement for growth but not copolymer accumulation is limited. Under such growth limitation conditions the tendency of the bacterium to produce and accumulate PHB homopolymer is avoided, and the production and accumulation of HV containing polymer is induced. Whilst it may be possible to induce copolymer accumulation by restricting the supply of oxygen to the bacterium, it is preferred to restrict the supply of one or more of the essential nutrients.
- the most practical elements to limit are nitrogen, phosphorus, or, less preferably, magnesium, sulphur or potassium.
- the nitrogen may be conveniently supplied in the form of an ammonium salt, whereas the phosphorus may be conveniently supplied as a phosphate.
- the substrate is preferably nitrogen free and so amide derivatives of the HV component are less preferred.
- the amount of assimilable nitrogen required is about 10 to 15% by weight of the desired weight of cells less the weight of the accumulated copolymer.
- Cultivation of the bacterium is preferably conducted so that the dry weight of the copolymer-containing cells is at least 30 g.1 -1 , preferably at least 80 g.1 -1 , and particularly at least 120 g.1 -1 .
- the bacterium used is capable of efficiently converting the HV component present in the substrate to HV monomer units. Specifically the bacterium can convert the HV component to HV monomer units at an efficiency, on a molar basis, of greater than 45%, particularly at least 60%, and especially between 70 and 80%, and further advantageously between 80 and 90%.
- those conditions under which a specific bacterium should be cultivated are those which maximise the efficiency of conversion.
- Cultivation of the bacterium preferably comprises a two stage process.
- the bacterium is preferably grown to a certain dry weight per liter, under non-growth limiting conditions on a readily metabolisable substrate, such as a carbohydrate, for example glucose.
- a readily metabolisable substrate such as a carbohydrate, for example glucose.
- the substrate is at least in part the HV component, and at least one nutrient required for growth is limited, such that the growth limiting conditions exist.
- the cultivation may be performed as a batch process, such that copolymer accumulation will occur as the amount of the nutrient required for growth but not copolymer accumulation becomes depleted.
- the cultivation may be performed as a continuous process, wherein a stream of culture is removed from the vessel, in which the bacterium is being cultivated, on a continuous or semi continuous basis.
- the stream removed from the vessel contains bacterium cells in a spent aqueous medium.
- the spent aqueous medium comprises residual quantities of nutrients and substrate.
- the flowrate of the stream leaving the vessel corresponds to the rate of addition of fresh aqueous medium to the vessel.
- the fresh aqueous medium supplied to the vessel contains nutrients and substrate in sufficient amounts to support accumulation of copolymer.
- the amount of that nutrient, used to limit the growth of the bacterium, which is fed to the vessel is such that little or none of that nutrient is present in the spent aqueous medium removed from the vessel.
- the spent aqueous medium is fed to at least one further aerated cultivation stage under batch or preferably continuous or semi-continuous operation, wherein additional copolymer accumulation is stimulated by the addition of fresh HV component containing substrate to the spent aqueous medium.
- the levels of nutrients and substrate may be adjusted in the spent aqueous medium after leaving the first cultivation stage such that optimum operation of the overall process is maintained.
- the cultivation of the bacterium may be conducted as a single stage process.
- the residence time of the aqueous medium in the vessel is made sufficiently long so as to allow exhaustion of the limiting nutrient, and for copolymer accumulation to occur.
- the HV component may be present as the sole source of carbon present in the substrate during all, or part of, the copolymer accumulation stage, or may be in admixture with other assimilable carbon sources.
- the concentration of the HV component in the aqueous medium depends on a number of factors, e.g. whether the process is batch or continuous, the percentage copolymer desired, the percentage of HV monomer units in the copolymer desired. Because the bacterium used is capable of synthesising and accumulating copolymer at high conversion efficiencies, the concentrating of the HV component in the medium to, and hence medium from, the process is relatively low. Generally, the concentration of the HV component at the point of harvest of the bacterium is preferably between 0.1 and 25, and particularly between 5 and 10 g.1 -1 .
- the HV component may be propanol, propionic acid, or a salt, ester, anhydride, amide, or halide thereof.
- CoA.SH is unesterified Coenzyme A
- CH 3 .CO.S.CoA is the acetyl thioester of Coenzyme A and is more commonly termed acetyl CoA,
- NADP is nicotinamide adenine dinucleotide phosphate in the oxidised state
- NADPH 2 is reduced NADP.
- the first step is the synthesis of acetyl CoA.
- This can be formed for example, from CoA and acetate, or by the decarboxylation of pyruvate, which is the product of the glycolysis of carbohydrates, or which can be formed by decarboxylation of oxaloacetate, the latter being a member of the tricarboxylic acid (TCA) cycle, otherwise known as the Krebbs cycle.
- TCA tricarboxylic acid
- the PHB is produced by a metabolic pathway involving the reactions:
- CH 3 .CO.CH 2 .CO.S.CoA is acetoacetyl CoA
- CH 3 .CHOH.CH 2 .CO.S.CoA is 3hydroxybutyryl CoA
- reaction 4 adds --O.CH(CH 3 ).CH 2 .CO-- to a growing polymer chain.
- CH 3 .CH 2 .CO.S.CoA is propionyl CoA
- CH 3 .CH 2 .CO.CH 2 .CO.S.CoA is 3 ketovaleryl CoA
- CH 3 .CH 2 .CHOH.CH 2 .CO.S.CoA is 3 hydroxyvaleryl CoA
- reaction 4a adds --O.CH(C 2 H 5 ).CH 2 .CO-- to a growing polymer chain.
- the substrate comprises not only an HV component but also a carbon source metabolisable to the required HB monomer intermediate, i.e. an HB component.
- a bacterium suitably adapted for use in the process of the present invention may be produced by the mutation of a PHB accumulating strain of Alcaligenes eutrophus, and by screening and selecting of the resultant mutants.
- NCIMB 40124 a strain, in particular as a pure culture, of Alcaligenes eutrophus designated NCIMB 40124, and mutants and variants derived therefrom.
- strain Alcaligenes eutropbus NCIMB 40124 was deposited at the National Collections of Industrial and Marine Bacteria Ltd. (NCIMB), PO Box 31, 135 Abbey Road, Aberdeen AB9 8DG, United Kingdom on the Mar. 24, 1989, under the terms and conditions of the Budapest Treaty.
- the strain Alcaligenes eutrophus NCIMB 40124, and useful mutants and variants derived therefrom, may be characterised by the following taxonomic description.
- the strain, and mutants and variants derived therefrom are able to produce and accumulate PHB in a manner similar to that of the parent strain NCIB 12080, produce and accumulate copolymers containing HB and HV monomer units at high HV component to HV monomer conversion efficiencies, grow on a substrate consisting of acetate, but show no grow on a substrate consisting of propionate.
- the combination of these growth, no growth, and polymer accumulation characteristics distinguish the new strains of Alcaligenes eutrophus from existing strains of Alcaligenes eutrophus.
- the evaluation of the growth/no growth characteristics, mentioned above, were conducted under non growth limiting conditions, on a substrate having a carbon content which was provided essentially by the material under test, i.e. acetate or propionate.
- Gram negative motile rods of approximate size 0.8 ⁇ m ⁇ 6.0 ⁇ m.
- Strains of Alcaligenes eutrophus in accordance with the present invention may be produced in a variety of ways, for example, transposon mutagenesis including excision of inserted transposons which are able to cause deletions, chemical mutagenesis using mutagens such as ethane methane sulphonate and mutations caused by invitro manipulation and subsequent recombination.
- Strain Alcaligenes eutrophus NCIMB 40124 was prepared in the following manner.
- the parent culture was Alcaligenes eutrophus NCIB 12080, available from the National Collection of Industrial and Marine Bacteria Ltd under the terms and conditions of the Budapest Treaty.
- the parent culture was grown in mineral salts medium, plus glucose at 1%, to an optical density of 0.9, as measured at 600 nm.
- a sample (10 mls) of the culture, as grown, was transferred to a 9 cm glass petri dish, and then irradiated with UV light at a dose level sufficient to achieve a kill of 99.9%.
- the irradiated culture was transferred to a flask containing mineral salts medium, plus glucose at 1%, and incubated, at 30° C., in the dark for about 16 hours.
- the culture was then centrifuged, and the resulting pellet resuspended in sterile distilled water.
- Colonies were identified that were able to grow on the glucose agar plates but not the propionate agar plates. These colonies were selected for further investigation.
- the selected colonies of putative mutants were screened for their ability to grow using glucose, or acetate, as a carbon source; their inability to grow on propionate; and their ability to produce and accumulate copolymer, comprising HB monomer and HV monomer units, when supplied with glucose and propionate under nitrogen limited conditions.
- One strain produced according to the hereinbefore described procedure is Alcaligenes eutrophus NCIMB 40124.
- aqueous medium containing the following, expressed as (g.1 -1 ), and having a pH of about 7 (controlled by ammonia addition) was prepared.
- a fermenter containing 31 of the above medium was inoculated with a starter culture of Alcaligenes eutrophus NCIMB 40124.
- the inoculated medium was incubated, at 30° C., for 24 hours until the phosphate content of the medium became limiting.
- Glucose, and propionic acid were then fed to the fermenter at rates of 10 g.hr -1 , and 3.3 g.hr -1 respectively for a further 48 hours.
- the cells containing the copolymer were harvested, freeze dried, and analysed for polymer content and composition.
- Example 1 was repeated, except that the flow rates of the glucose and the propionic acid were 6.4 g.hr -1 , and 0.7 g.hr -1 , respectively.
- Example 1 was repeated, except strain Alcaligenes eutrophus NCIB 12080, was used instead of strain Alcaligenes eutrophus NCIMB 40124.
- Example 2 was repeated, except strain Alcaligenes eutrophus NCIB 12080, was used instead of strain Alcaligenes eutropbus NCIMB 40124.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polyesters Or Polycarbonates (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
--O.CH(CH.sub.3).CH.sub.2.CO--
--O.C(CH.sub.3)═CH.CO--
--O.CH(C.sub.2 H.sub.5).CH.sub.2.CO--
______________________________________ Catalase + Kovacs Oxidase + O-F Glucose very weakly oxidative Pyocyanin - Fluorescence - L-Arginine CSU - Betaine CSU - Glucose CSU + Lactate CSU + Acetate CSU + CSU Arabinose - Meso-inositol - Xylose - Gas Glucose - ONPG - Arginine Moller - Lysine Moller - Ornithine Moller - NO.sub.3.sup.- -to N.sub.2.sup.- NO.sub.3 to N.sub.2 + at 37° C. DNA ase - Gel stab. - Gel plate - Casein - Starch - Lecithin egg - Lipase egg - NH.sub.3 weakly positive Indole - H.sub.2 S - Tween 80 + Urease + ______________________________________
______________________________________ MgSO.sub.4.7H.sub.2 O 2.2 K.sub.2 SO.sub.4 3.0 Na.sub.2 SO.sub.4 0.18 FeSO.sub.4.7H.sub.2 O 0.18 Glucose 13.0 Trace elements 3.0 (mls) Phosphoric Acid 6.5 (mls of 1.1M) ______________________________________
______________________________________ Example % HV Component No. In Copolymer ______________________________________ 1 29 2 7 C3 10 C4 5 ______________________________________
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/103,155 US5364778A (en) | 1989-12-08 | 1993-08-09 | Copolymer production |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898927794A GB8927794D0 (en) | 1989-12-08 | 1989-12-08 | Copolymer production |
GB8927791 | 1989-12-08 | ||
US62410290A | 1990-12-10 | 1990-12-10 | |
US08/103,155 US5364778A (en) | 1989-12-08 | 1993-08-09 | Copolymer production |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US62410290A Continuation | 1989-12-08 | 1990-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
US5364778A true US5364778A (en) | 1994-11-15 |
Family
ID=10667644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/103,155 Expired - Lifetime US5364778A (en) | 1989-12-08 | 1993-08-09 | Copolymer production |
Country Status (13)
Country | Link |
---|---|
US (1) | US5364778A (en) |
EP (1) | EP0431883B1 (en) |
JP (1) | JP3036851B2 (en) |
KR (1) | KR100223341B1 (en) |
AT (1) | ATE149204T1 (en) |
AU (1) | AU637657B2 (en) |
BR (1) | BR9006231A (en) |
CA (1) | CA2031888C (en) |
DE (1) | DE69029993T2 (en) |
GB (2) | GB8927794D0 (en) |
IN (1) | IN177461B (en) |
NZ (1) | NZ236394A (en) |
ZA (1) | ZA909816B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225438B1 (en) | 2000-01-31 | 2001-05-01 | The Procter & Gamble Company | Medium chain length PHA copolymer and process for producing same |
US6340580B1 (en) * | 1999-05-12 | 2002-01-22 | Metabolix, Inc. | Methods for purifying polyhydroxy alkanoates |
US6600029B1 (en) | 1995-12-19 | 2003-07-29 | Regents Of The University Of Minnesota | Metabolic engineering of polyhydroxyalkanoate monomer synthases |
US20040014197A1 (en) * | 1998-03-30 | 2004-01-22 | Metabolix, Inc. | Microbial strains and process for the manufacture of biomaterials |
US20070161097A1 (en) * | 2005-02-28 | 2007-07-12 | The Procter & Gamble Company | Deregulated bacteria with improved polyhydroxyalkanoate production |
WO2013072723A1 (en) | 2011-11-17 | 2013-05-23 | Bio-On S.R.L. | Process for producing microbial copolyesters from sucrose-containing feedstocks |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9011777D0 (en) * | 1990-05-25 | 1990-07-18 | Ici Plc | Hv/hb copolymer production |
ES2061405B1 (en) * | 1993-05-04 | 1995-11-01 | Univ Granada | PRODUCTION OF POLYHYDROXIALCANOATES (PHAS) BY AZOTOBACTER CHROOCOCCUM PHA. |
GB9419082D0 (en) * | 1994-09-22 | 1994-11-09 | Zeneca Ltd | Copolyesters |
PL2770836T3 (en) | 2011-10-25 | 2018-12-31 | Marrone Bio Innovations, Inc. | Chromobacterium formulations, compostions, metabolites and their uses |
RU2484140C1 (en) * | 2011-12-26 | 2013-06-10 | Федеральное Государственное Автономное Образовательное Учреждение Высшего Профессионального Образования "Сибирский Федеральный Университет" | Method of producing copolymer of 3-hydroxybutyric acid and 3-hydroxyvaleric acid |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0046344A2 (en) * | 1980-08-19 | 1982-02-24 | Imperial Chemical Industries Plc | Fermentation process |
EP0052459A1 (en) * | 1980-11-18 | 1982-05-26 | Imperial Chemical Industries Plc | Beta-hydroxybutyrate polymers |
EP0069497A2 (en) * | 1981-07-07 | 1983-01-12 | Imperial Chemical Industries Plc | Copolyesters and process for their production |
US4477654A (en) * | 1981-07-07 | 1984-10-16 | Imperial Chemical Industries Plc | 3-Hydroxybutyrate polymers |
EP0124309A2 (en) * | 1983-04-28 | 1984-11-07 | Imperial Chemical Industries Plc | Extraction process |
EP0204442A2 (en) * | 1985-05-28 | 1986-12-10 | Imperial Chemical Industries Plc | Copolymer production |
EP0288908A2 (en) * | 1987-04-28 | 1988-11-02 | Mitsubishi Gas Chemical Company, Inc. | Process for production of a random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate |
US4788979A (en) * | 1986-09-23 | 1988-12-06 | American Cyanamid Company | Bioabsorbable coating for a surgical article |
US5096819A (en) * | 1988-11-07 | 1992-03-17 | The Governors Of The University Of Alberta | Hyperproduction of poly-β-hydroxybutyrate during exponential growth by mutant strains of Azotobacter vinelandii |
-
1989
- 1989-12-08 GB GB898927794A patent/GB8927794D0/en active Pending
-
1990
- 1990-12-03 GB GB909026238A patent/GB9026238D0/en active Pending
- 1990-12-04 EP EP90313133A patent/EP0431883B1/en not_active Expired - Lifetime
- 1990-12-04 DE DE69029993T patent/DE69029993T2/en not_active Expired - Fee Related
- 1990-12-04 AT AT90313133T patent/ATE149204T1/en not_active IP Right Cessation
- 1990-12-06 IN IN1235DE1990 patent/IN177461B/en unknown
- 1990-12-06 ZA ZA909816A patent/ZA909816B/en unknown
- 1990-12-07 JP JP2400947A patent/JP3036851B2/en not_active Expired - Lifetime
- 1990-12-07 AU AU67827/90A patent/AU637657B2/en not_active Ceased
- 1990-12-07 BR BR909006231A patent/BR9006231A/en not_active IP Right Cessation
- 1990-12-07 NZ NZ236394A patent/NZ236394A/en unknown
- 1990-12-08 KR KR1019900020175A patent/KR100223341B1/en not_active IP Right Cessation
- 1990-12-10 CA CA002031888A patent/CA2031888C/en not_active Expired - Fee Related
-
1993
- 1993-08-09 US US08/103,155 patent/US5364778A/en not_active Expired - Lifetime
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0046344A2 (en) * | 1980-08-19 | 1982-02-24 | Imperial Chemical Industries Plc | Fermentation process |
US4433053A (en) * | 1980-08-19 | 1984-02-21 | Imperial Chemical Industries Plc | Fermentation process for the production of poly(β-hydroxy butyric acid) |
EP0052459A1 (en) * | 1980-11-18 | 1982-05-26 | Imperial Chemical Industries Plc | Beta-hydroxybutyrate polymers |
EP0069497A2 (en) * | 1981-07-07 | 1983-01-12 | Imperial Chemical Industries Plc | Copolyesters and process for their production |
US4477654A (en) * | 1981-07-07 | 1984-10-16 | Imperial Chemical Industries Plc | 3-Hydroxybutyrate polymers |
EP0124309A2 (en) * | 1983-04-28 | 1984-11-07 | Imperial Chemical Industries Plc | Extraction process |
EP0204442A2 (en) * | 1985-05-28 | 1986-12-10 | Imperial Chemical Industries Plc | Copolymer production |
US4788979A (en) * | 1986-09-23 | 1988-12-06 | American Cyanamid Company | Bioabsorbable coating for a surgical article |
EP0288908A2 (en) * | 1987-04-28 | 1988-11-02 | Mitsubishi Gas Chemical Company, Inc. | Process for production of a random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate |
US4997909A (en) * | 1987-04-28 | 1991-03-05 | Mitsubishi Gas Chemical Company, Inc. | Random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate, and process for production thereof |
US5096819A (en) * | 1988-11-07 | 1992-03-17 | The Governors Of The University Of Alberta | Hyperproduction of poly-β-hydroxybutyrate during exponential growth by mutant strains of Azotobacter vinelandii |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6600029B1 (en) | 1995-12-19 | 2003-07-29 | Regents Of The University Of Minnesota | Metabolic engineering of polyhydroxyalkanoate monomer synthases |
US20040014197A1 (en) * | 1998-03-30 | 2004-01-22 | Metabolix, Inc. | Microbial strains and process for the manufacture of biomaterials |
US8728778B2 (en) | 1998-03-30 | 2014-05-20 | Metabolix, Inc. | Microbial strains and processes for the manufacture of biomaterials |
US8748139B2 (en) | 1998-03-30 | 2014-06-10 | Metabolix, Inc. | Microbial strains and process for the manufacture of biomaterials |
US6340580B1 (en) * | 1999-05-12 | 2002-01-22 | Metabolix, Inc. | Methods for purifying polyhydroxy alkanoates |
US6225438B1 (en) | 2000-01-31 | 2001-05-01 | The Procter & Gamble Company | Medium chain length PHA copolymer and process for producing same |
US20070161097A1 (en) * | 2005-02-28 | 2007-07-12 | The Procter & Gamble Company | Deregulated bacteria with improved polyhydroxyalkanoate production |
WO2013072723A1 (en) | 2011-11-17 | 2013-05-23 | Bio-On S.R.L. | Process for producing microbial copolyesters from sucrose-containing feedstocks |
Also Published As
Publication number | Publication date |
---|---|
AU6782790A (en) | 1991-06-13 |
EP0431883A3 (en) | 1991-11-06 |
DE69029993T2 (en) | 1997-07-10 |
JPH05236973A (en) | 1993-09-17 |
EP0431883A2 (en) | 1991-06-12 |
EP0431883B1 (en) | 1997-02-26 |
NZ236394A (en) | 1993-04-28 |
GB8927794D0 (en) | 1990-02-14 |
KR910012251A (en) | 1991-08-07 |
AU637657B2 (en) | 1993-06-03 |
JP3036851B2 (en) | 2000-04-24 |
ZA909816B (en) | 1991-11-27 |
CA2031888A1 (en) | 1991-06-09 |
ATE149204T1 (en) | 1997-03-15 |
CA2031888C (en) | 2000-05-09 |
DE69029993D1 (en) | 1997-04-03 |
KR100223341B1 (en) | 1999-10-15 |
GB9026238D0 (en) | 1991-01-16 |
IN177461B (en) | 1997-01-18 |
BR9006231A (en) | 1991-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4477654A (en) | 3-Hydroxybutyrate polymers | |
Fritzsche et al. | Production of unsaturated polyesters by Pseudomonas oleovorans | |
EP0069497B1 (en) | Copolyesters and process for their production | |
US5126255A (en) | Copolymer production | |
JP2006204255A (en) | ACETYL-CoA ACYLTRANSFERASE GENE-BROKEN POLYHYDROXYALKANOATE-PRODUCING MICROORGANISM, AND METHOD FOR PRODUCING POLYHYDROXYALKANOATE THEREWITH | |
KR20040030746A (en) | Microorganisms used for production of polyhydroxyalkanoate | |
US5364778A (en) | Copolymer production | |
EP1113076B1 (en) | Method for producing microbial polyester | |
JPH0515383A (en) | Plastic material consisting of beta- hydroxybutylate copolymer and method for forming the same | |
JPH057492A (en) | Production of copolymer | |
US6080562A (en) | HV/HB copolymer production | |
US5387513A (en) | Microbiological production of polyesters having C8 and/or C10 monomer repeat units | |
US5264546A (en) | Copolymer production | |
JP2002253285A (en) | Method for producing polyhydroxyalkanoate | |
US5266470A (en) | Copolymer production | |
JP3768835B2 (en) | Polyhydroxyalkanoate containing 3-hydroxy-substituted benzoylalkanoic acid as monomer unit and process for producing the same | |
JPH0748438A (en) | Copolymer and production thereof | |
JP2005097633A (en) | Polyhydroxyalkanoate, method for producing the same and microorganism usable for the method | |
KR950010814B1 (en) | New microorganism psendomonas putida | |
EP0667913A1 (en) | Phb-producing microorganism and process for removing clycerol from a culture medium | |
JPH0564592A (en) | Production of bio-polyester |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ZENECA LIMITED, ENGLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IMPERIAL CHEMICAL INDUSTRIES PLC;REEL/FRAME:006965/0039 Effective date: 19931102 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
AS | Assignment |
Owner name: MONSANTO COMPANY, MISSOURI Free format text: SECURITY INTEREST;ASSIGNOR:METABOLIX, INC.;REEL/FRAME:012066/0562 Effective date: 20010511 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
FEPP | Fee payment procedure |
Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 12 |
|
AS | Assignment |
Owner name: METABOLIX, INC., MASSACHUSETTS Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MONSANTO COMPANY;REEL/FRAME:018498/0719 Effective date: 20061106 |
|
AS | Assignment |
Owner name: METABOLIX, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MONSANTO COMPANY;REEL/FRAME:018505/0713 Effective date: 20010514 |
|
AS | Assignment |
Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BYROM, DAVID;REEL/FRAME:018505/0805 Effective date: 19901204 |
|
FEPP | Fee payment procedure |
Free format text: PAT HOLDER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: LTOS); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |